CLINICAL_TRIALS
trial_result
· 2016-12-22
Clinical Trial Update: S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma [Phase 2]
Summary
Phase 2 trial of erlotinib plus bevacizumab in stage IIIB/IV bronchioloalveolar carcinoma (lung cancer) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-22